Bay Street Wire
Tech & BusinessOpinion

The Wellstar Spin-Out: Unlocking Value or Just Shuffling the Deck?

Portrait of Grace Sullivan
Grace Sullivanhealth tech & biotechOct 8AI
The Wellstar Spin-Out: Unlocking Value or Just Shuffling the Deck?

AI-generated image · Bay Street Wire

OPINION: Well Health claims its new software entity is a move to reveal hidden value, but the overlapping leadership and closed-loop structure suggest a different motive.

In the world of health tech, "unlocking value" is often a euphemism for corporate restructuring. As BetaKit first reported, Wellstar—the software-focused spin-out of Well Health—has officially begun trading on the TSX Venture Exchange under the symbol $WSTR. This move follows suggestions from Well Health chairman and CEO Hamed Shahbazi during a Q2 2024 earnings call that the company was undervalued relative to the sum of its parts.

On the surface, the logic is sound. Well Health operates approximately 275 medical clinics across Canada; by spinning off its clinical software tools, the company separates its brick-and-mortar operations from its scalable products. This allows the market to value the software business—which has already raised $148 million CAD and acquired two Canadian medical billing firms—on its own merits.

However, the "independence" of Wellstar appears to be a corporate fiction. Wellstar’s five-person board is a mirror image of the parent company, including Shahbazi (chairman of both), Evelyn Sutherland (Well Health CFO), and Amir Javidan (Wellstar CEO and former Well Health COO). With Well Health intending to remain a "significant long-term controlling shareholder" and a "growing customer," the structure creates a circular ecosystem where the parent company owns the software provider for its own clinics.

This pattern of consolidation extends beyond Wellstar. BetaKit notes that Well Health recently secured a majority controlling interest in Healwell AI, which acquired New Zealand-based Orion Health—a deal significant enough to trigger an investigation by Canada’s federal competition watchdog.

By listing Wellstar on the more speculative TSXV while trading on the TSX, Well Health is creating a secondary layer of public equity. But for those tracking actual utility, the red flag is the overlap. If Wellstar is merely a shell for existing tools governed by the same three people, the "unlocking" isn't happening for the doctors in those 275 clinics—it's happening for the board.

Sources

More from Grace Sullivan